A PMT-Block test bench Adragna, P.; Antonaki, A.; Boudagov, I. ...
Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment,
08/2006, Letnik:
564, Številka:
1
Journal Article
Recenzirano
The front-end electronics of the ATLAS hadronic calorimeter (Tile Cal) is housed in a unit, called
PMT-Block. The PMT-Block is a compact instrument comprising a light mixer, a PMT together with its ...divider and a
3-in-1 card, which provides shaping, amplification and integration for the signals. This instrument needs to be qualified before being assembled on the detector. A PMT-Block test bench has been developed for this purpose. This test bench is a system which allows fast, albeit accurate enough, measurements of the main properties of a complete PMT-Block. The system, both hardware and software, and the protocol used for the PMT-Blocks characterization are described in detail in this report. The results obtained in the test of about 10
000 PMT-Blocks needed for the instrumentation of the ATLAS (LHC-CERN) hadronic Tile Calorimeter are also reported.
Highlights • FLT3-L is implicated in MM angiogenesis. • Serum levels of FLT3-L can be used as angiogenic markers MM. • Serum levels of FLT3-L may serve as markers of MM activity.
This paper presents a search for the t-channel exchange of an R-parity violating scalar top quark (??) in the e.sup.+ or -μ.sup.∓ continuum using 2.1 fb.sup.-1 of data collected by the ATLAS detector ...in square root of s = 7 TeV pp collisions at the Large Hadron Collider. Data are found to be consistent with the expectation from the Standard Model backgrounds. Limits on R-parity-violating couplings at 95% C.L. are calculated as a function of the scalar top mass (m.sub.??). The upper limits on the production cross section for pp → eμX, through the t-channel exchange of a scalar top quark, ranges from 170 fb for m.sub.?? = 95 GeV to 30 fb for m.sub.?? = 1000 GeV.
This Letter presents the first search for supersymmetry in final states containing one isolated electron or muon, jets, and missing transverse momentum from sqrt{s} = 7 TeV proton-proton collisions ...at the LHC. The data were recorded by the ATLAS experiment during 2010 and correspond to a total integrated luminosity of 35 pb-1. No excess above the standard model background expectation is observed. Limits are set on the parameters of the minimal supergravity framework, extending previous limits. For A_0 = 0 GeV, tan beta = 3, mu > 0 and for equal squark and gluino masses, gluino masses below 700 GeV are excluded at 95% confidence level.
The ATLAS detector is used to search for high-mass states, such as heavy charged gauge bosons (W', W*) decaying to a charged lepton (electron or muon) and a neutrino. Results are presented based on ...the analysis of pp collisions at a center-of-mass energy of 7 TeV corresponding to an integrated luminosity of 36 pb-1. No excess beyond standard model expectations is observed. A W' with sequential standard model couplings is excluded at 95% confidence level for masses below 1.49 TeV, and a W*(charged chiral boson) for masses below 1.47 TeV.
First measurements of the W -> lnu and Z/gamma* -> ll (l = e, mu) production cross sections in proton-proton collisions at sqrt(s) = 7 TeV are presented using data recorded by the ATLAS experiment at ...the LHC. The results are based on 2250 W -> lnu and 179 Z/gamma* -> ll candidate events selected from a data set corresponding to an integrated luminosity of approximately 320 nb-1. The measured total W and Z/gamma*-boson production cross sections times the respective leptonic branching ratios for the combined electron and muon channels are $\stotW$ * BR(W -> lnu) = 9.96 +- 0.23(stat) +- 0.50(syst) +- 1.10(lumi) nb and $\stotZg$ * BR(Z/gamma* -> ll) = 0.82 +- 0.06(stat) +- 0.05(syst) +- 0.09(lumi) nb (within the invariant mass window 66 < m_ll < 116 GeV). The W/Z cross-section ratio is measured to be 11.7 +- 0.9(stat) +- 0.4(syst). In addition, measurements of the W+ and W- production cross sections and of the lepton charge asymmetry are reported. Theoretical predictions based on NNLO QCD calculations are found to agree with the measurements.
Nucl.Instrum.Meth. A564 (2006) 597-607 The front-end electronics of the ATLAS hadronic calorimeter (Tile Cal) is
housed in a unit, called {\it PMT-Block}. The PMT-Block is a compact instrument
...comprising a light mixer, a PMT together with its divider and a {\it 3-in-1}
card, which provides shaping, amplification and integration for the signals.
This instrument needs to be qualified before being assembled on the detector. A
PMT-Block test bench has been developed for this purpose. This test bench is a
system which allows fast, albeit accurate enough, measurements of the main
properties of a complete PMT-Block. The system, both hardware and software, and
the protocol used for the PMT-Blocks characterisation are described in detail
in this report. The results obtained in the test of about 10000 PMT-Blocks
needed for the instrumentation of the ATLAS (LHC-CERN) hadronic Tile
Calorimeter are also reported.
A PMT-Block test bench Adragna, P; Antonaki, A; Boudagov, I ...
arXiv.org,
05/2006
Paper
Odprti dostop
The front-end electronics of the ATLAS hadronic calorimeter (Tile Cal) is housed in a unit, called {\it PMT-Block}. The PMT-Block is a compact instrument comprising a light mixer, a PMT together with ...its divider and a {\it 3-in-1} card, which provides shaping, amplification and integration for the signals. This instrument needs to be qualified before being assembled on the detector. A PMT-Block test bench has been developed for this purpose. This test bench is a system which allows fast, albeit accurate enough, measurements of the main properties of a complete PMT-Block. The system, both hardware and software, and the protocol used for the PMT-Blocks characterisation are described in detail in this report. The results obtained in the test of about 10000 PMT-Blocks needed for the instrumentation of the ATLAS (LHC-CERN) hadronic Tile Calorimeter are also reported.
Abstract Background and Aims Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with better cardiovascular outcomes and with nephroprotection independent of diabetes status. Recent ...data suggest that SGLT2i significantly reduce proteinuria in patients with IgA nephropathy (IgAN). However, they often cause an initial decline in estimated glomerular filtration rate (eGFR). The aim of our study was to assess the degree of proteinuria reduction after SGLT2i treatment in IgAN and its possible association with the initial functional dip in eGFR. Method 63 adult patients with biopsy-proven IgA nephropathy, eGFR ≥ 30 mL/min/1.73 m2 (CKD-epi), and total urine protein of >0.5 grams/day at screening were included. Patients with secondary IgAN were excluded. All receiving maximally tolerated RASi for at least 12 weeks. All patients started dapagliflozin 10 mg once per day after baseline data were registered. The total follow-up was 12 months. The main outcome was the decline in eGFR and the reduction in 24-hour proteinuria from SGLT2i initiation to 1,3, 6, 9, 12 months, end-stage renal disease, or kidney or cardiovascular death. Results 55 patients (38/17 M/F), with mean age of 44,2±18,3 years, completed follow up. 8 patients discontinued treatment due to adverse events attributed to dapagliflozin. At baseline eGFR was 66.17±19,7 ml/min/1.73 m2 and Upr: 2356±1023 mg/24H. There was a transient decline in eGFR, 30 days after initiation of dapagliflozin (66.17±19,7 min/1.73 m2 at baseline to 57 ml/min/1.73 m2) but then, there was an improvement at month 3 from baseline. The Upr/24H difference for dapagliflozin was −25.1% (95% CI −27.5, −23.2; p < 0.001) at the end of follow-up (month 12). Proteinuria reduction was similar across all eGFRs. Notably, a significant correlation was found between the initial eGFR dip and percentage proteinuria reduction in the 12th month. (R = –0.23; p = 0.03). Consistent results of dapagliflozin treatment on proteinuria were found in all analysis subgroups including sex, baseline proteinuria, systolic blood pressure, and body mass index. No hypoglycaemic events were reported and no deaths occurred. Conclusion In the present study, the use of SGLT2i was associated with a significant reduction of proteinuria in patients with IgA nephropathy in patients with maximally tolerated RASi. Higher initial eGFR dip after treatment initiation was a predictor of a significantly higher reduction in proteinuria at the end of follow-up. The correlation between eGFR dip and proteinuria reduction perhaps reflects the intraglomerular pressure reduction, mediated by tubuloglomerular feedback, one of the numerous.
PDF
